Consensus Statement on the Outcome of the European Herbal Health Products Summit – Which Way Forward?

Abstract Herbal medicinal products are a vital part of the healthcare system in Europe and beyond. Being predominantly sold as non-prescription medicines in pharmacies, they are very popular with patients, physicians, and pharmacists and are therefore an important part of self-medication. Interest in this sector has recently gained momentum, reflecting the ongoing revision of the general pharmaceutical legislation and the recent discussion on nutrition and health claims on foods based on the implementation report of Regulation (EC) No 1924/2006 by the European Parliament 1 . Therefore, on 20th February 2024, the Society for Medicinal Plant and Natural Product Research (GA), in collaboration with the German Pharmaceutical Industry Association (BPI) and the German Medicines Manufacturersʼ Association (BAH, now Pharma Deutschland), hosted an in-person summit in Brussels entitled ‘European Herbal Health Products Summit – Which way forward?ʼ. The summit featured a wide range of speakers, including policymakers, regulatory authorities, industry representatives, and academic experts. It was divided into several sessions covering topics such as the future and relevance of herbal medicinal products in the EU, the revision of the EU pharmaceutical legislation, and the resulting impact on herbal medicinal products. Furthermore, the discussions delved into the “Health Claims Regulation” – the European Parliamentʼs implementation report and the related regulatory challenges of herbal medicinal products at an EU level. This consensus paper summarises the current status and provided recommendations to pave the way for future strategies to ascertain the continued use of herbal medicinal products as an important therapeutic option for patients.

• Publication year

  2024

• Venue

  Planta Medica

• Publication date

  2024-07-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/a-2419-1602PMID 39389561PMCID 11557087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Community code relating to medicinal products for human use

  2014cited by this paper

• Challenges in performing clinical research on herbal products – experiences from Switzerland and the UK

  2026cites this paper
• Passionflower (Passiflora incarnata) : Quality of Food Supplements Versus Registered Herbal Medicinal Products

  2025cites this paper
• Traditional Remedies for Diarrheal Diseases: Successes and Challenges

  2025cites this paper
• Pharmaceutical quality of herbal medicinal products and dietary supplements - a case study with oral solid formulations containing Lavandula species.

  2025cites this paper
• Passionsblumenkraut (Passiflorae herba)  

  2025cites this paper
• Herb-Induced Liver Injury

  2025cites this paper
• The pharmaceutical quality and clinical outcome – A case study of Lavandula herbal medicinal products and its impact on managing anxiety, stress, and sleep disorders

  2025cites this paper